Skip to Main Content
It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.

Resources for Psychopharmacology



To find articles about pharmacogenomic and cultural considerations of medications, try the searches below. The broad search will have more results, and the specific search will have fewer results.

For articles on a specific group or population, you can search using the name of that group/population and the drug name or drug class. For example, "Native Americans and psychotropic drugs." Use the search box at the top of the library homepage, or one of the selected databases listed further down on the homepage.



Below are suggested articles to help with pharmacogenomic and cultural considerations related to each of the psychotropic drug classes.


Bai, Y., Chen, G., Yang, H., & Gao, K. (2020). Do Asian and North American patients with bipolar disorder have similar efficacy, tolerability, and safety profile during clinical trials with atypical antipsychotics? Journal of Affective Disorders, 261, 259-270.

Canevelli, M., Bruno, G., Grande, G., Quarata, F., Raganato, R., Remiddi, F., Valletta, M., Zaccaria, V., Vanacore, N., & Cesari, M. (2019). Race reporting and disparities in clinical trials on Alzheimer's disease: A systematic review. Neuroscience & Biobehavioral Reviews, 101, 122-128.

Jerome, R. N., Pulley, J. M., Sathe, N. A., Krishnaswami, S., Dickerson, A. B., Worley, K. J., & Wilkins, C. H. (2020). Exploring biologic predictors response disparities to atypical antipsychotics among Blacks: A quasi-systematic review. Ethnicity & Disease, 30(Suppl 1), 229–240.

Kishi T., Ikuta T., Matsunaga S., Matsuda Y., Oya K., & Iwata N. (2017). Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population. Neuropsychiatric Disease and Treatment, 2017(13), 1281-1302.

Stauffer, V., Sniadecki, J., Piezer, K., Gatz, J., Kollack-Walker, S., Hoffmann, V., Conley, R., & Durell, T. (2010). Impact of race on efficacy and safety during treatment with olanzapine in schizophrenia, schizophreniform or schizoaffective disorder. BMC Psychiatry, 10, Article 89.